Bioton SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioton SA with three other
pharmaceutical manufacturers in Europe:
Bosnalijek d.d. Sarajevo
sales of 153.24 million Bosnian Convertible Marks [US$88.68 million]
Allergy Therapeutics PLC
of the United Kingdom
(£64.14 million [US$81.60 million]
of which 100%
was Pharmaceuticals), and
based in Romania
(336.90 million Romanian Leu [US$82.09 million]
During the year ended December of 2017, sales at
Bioton SA were 361.65 million Polish New Zlotys (US$95.37 million).
increase of 30.3%
versus 2016, when the company's sales were 277.61 million Polish New Zlotys.
Despite this increase, sales are still
below the level achieved in 2015, when Bioton SA
reported sales of 404.41 million Polish New Zlotys.
Sales of Biolek saw an increase
that was more than double the company's growth rate: sales were up
113.3% in 2017, from
607,000.00 Polish New Zlotys to 1.30 million Polish New Zlotys.